Association between NT‐proBNP and false‐positive Coombs test in patients with heart failure and elevated NT‐proBNP
Vox Sanguinis · 2026-08 · 121 (8) · 1245-1249
DOI: 10.1111/vox.70284 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Vox Sanguinis, online erschienen am 07.05.2026. Verfasst von Ana Lamilla Álvarez und 12 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Department, Valencia General University Hospital, Valencia, Spain. Hauptthemen laut MEDLINE: Natriuretic Peptide, Brain, Heart Failure, Coombs Test, Peptide Fragments. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background and Objectives The human antiglobulin test or Coombs' test is a key tool in the diagnosis and classification of haemolytic anaemia and could present as falsely positive. A retrospective study has described that B‐type natriuretic peptide (NT‐proBNP), a biomarker used for heart failure (HF), could be an additional cause of false positives in the Coombs test. Materials and Methods A prospective, observational, single‐centre study was conducted in adult patients diagnosed with HF between October 2024 and March 2025 at a tertiary hospital. The Coombs' test was considered as false positive in cases in which the specificity of the test included immunoglobulin G (IgG), the subsequent elution yielded a negative result, and blood haemolysis parameters were within normal ranges.
Results
Thirty‐six patients were included, of whom nine (25%) had a false‐positive Coombs test. These patients had significantly higher levels of NT‐proBNP (10,825 pg/mL [2587–35,000] vs. 3314 pg/mL [278–11,856], p = 0.0076) and lower glomerular filtration rate (35.3 mL/min/1.73 m 2 [23.6–46.3] vs. 63.3 mL/min/1.73 m 2 [21.9–90.0], p = 0.0055) compared to patients with a negative Coombs test. No statistically significant associations were found with drugs used concomitantly for HF.
Conclusion
The results suggest that elevated NT‐proBNP could also be a cause of false positives in the Coombs test.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Internal Medicine Department, Valencia General University Hospital, Valencia, Spain.
- Haematology and Haemotherapy Department, Valencia General University Hospital, Valencia, Spain.
- Cardiology Department, Valencia General University Hospital, Valencia, Spain.
ORCID-Profile: Ana Lamilla Álvarez, Lorenzo Fácila Rubio
Zitieren
APA
Lamilla Álvarez, A., Cámara Rodenas, M. A., Russo Botero, S., Aracil Boigues, P., Játiva Sáez, C., Vidal Rico, E., Santos Cañamares, E., Rangel Algaba, A., Ortiz-Zuluaga, S., Marco Buades, J. E., Fácila Rubio, L., Pérez-Silvestre, J., & López-Pavía, M. E. (2026). Association between NT‐proBNP and false‐positive Coombs test in patients with heart failure and elevated NT‐proBNP. Vox Sanguinis, 121(8), 1245-1249. https://doi.org/10.1111/vox.70284
Vancouver
Lamilla Álvarez A, Cámara Rodenas MA, Russo Botero S, Aracil Boigues P, Játiva Sáez C, Vidal Rico E, et al. Association between NT‐proBNP and false‐positive Coombs test in patients with heart failure and elevated NT‐proBNP. Vox Sanguinis. 2026;121(8):1245-1249. doi:10.1111/vox.70284
BibTeX
@article{Lamillalvarez2026,
author = {Lamilla Álvarez, Ana and Cámara Rodenas, María Asunción and Russo Botero, Sofía and Aracil Boigues, Pau and Játiva Sáez, Cristina and Vidal Rico, Elena and Santos Cañamares, Elena and Rangel Algaba, Alma and Ortiz-Zuluaga, Sebastian and Marco Buades, Josefa Esperanza and Fácila Rubio, Lorenzo and Pérez-Silvestre, José and López-Pavía, María de la Encarnación},
title = {Association between NT‐proBNP and false‐positive Coombs test in patients with heart failure and elevated NT‐proBNP},
journal = {Vox Sanguinis},
year = {2026},
volume = {121},
number = {8},
pages = {1245--1249},
doi = {10.1111/vox.70284}
}
EUVIMED